Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01253031 · ClinicalTrials.gov registry record
Working Memory Changes With Aging and Hearing Loss
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 63
- Enrollment target
NCT01253031: Completed study, sponsored by VA Office of Research and Development.
NCT01253031 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 63 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01253031 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 63 participants
- Enrollment target
Study Summary
Hearing loss is one of the most common health concerns affecting 1 in 3 Americans over 60 years of age rising to 1 in 2 for those over 85 years old. Contributions to hearing abilities provided by cognitive and memory processes are universally recognized as essential to adequate speech communication, but these processes are not well understood. Cognitive limitations in the ability to rapidly process sequential sounds occur with all listeners but may have more impact on older Veterans with and without hearing impairment. The purpose of this study is to examine and more thoroughly characterize the change in auditory working memory with hearing loss and increasing age. Young and older listeners with and without hearing loss will listen and report on two target sounds embedded in a stream of rapidly occurring sound. The investigators expect that older listeners without hearing loss will have more difficulty than young listeners but that older listeners with hearing impairment will have the most difficulty with this task even when the sounds they are listening to are adjusted to compensate for their hearing loss.
Primary Outcome
The subjects will be trained to hear each target sound in a sequence of sounds. The target sounds will vary in terms of how closely they occur to each other. Closer (in time, also called lag time) targets will be harder to hear than far apart (in time) targets.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-12 |
What the finished NCT01253031 record still lists
NCT01253031 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 63 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01253031 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01253031 about?
NCT01253031 is a clinical study titled "Working Memory Changes With Aging and Hearing Loss". Hearing loss is one of the most common health concerns affecting 1 in 3 Americans over 60 years of age rising to 1 in 2 for those over 85 years old. Contributions to hearing abilities provided by cognitive and memory processes are universally recognized as essential to adequate speech communication,...
What is the current status of trial NCT01253031?
This trial is currently completed. The enrollment target is 63 participants. The study started on 2011-03. Estimated completion is 2012-12.
Who is sponsoring clinical trial NCT01253031?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia